Literature DB >> 6207064

Human proinsulin-specific antigenic determinants identified by monoclonal antibodies.

O D Madsen, B H Frank, D F Steiner.   

Abstract

Antigenic determinants recognized by human proinsulin (HPI)-specific monoclonal antibodies (Mabs) and Mabs crossreacting with free human C-peptide (HCP) were mapped by using various forms of purified, partially converted HPI intermediates. Two HPI-specific mouse Mabs (GS-4G9 and GS-9A8) reacted with the same antigenic determinant, GS, which was localized to the site of linkage of the B-chain to the C-peptide (Arg-Arg) at positions 31-32. These antibodies bind with equal efficiency to C65-A1 split proinsulin and to intact HPI. The binding of C32-C33 split proinsulin is markedly reduced. A rat Mab (GN-VIIB6), which crossreacts with free HCP in addition to HPI, reacted similarly with various HPI intermediates as it had with the corresponding synthetic HCP fragments, as previously reported (see ref. 9). This determinant (GN) is a three-dimensional structure composed of residues located in two separate regions in the C-peptide segment (positions 40-45 and 57-63). Reduced, carboxymethylated HPI retains the GN-determinant, whereas all insulin-like immunoreactivity identified with a conventional guinea pig insulin antiserum is completely lost. The binding of the two GS Mabs to the denatured HPI was reduced by 40-50% compared with intact HPI. It is concluded that the strong GN-determinant can readily form in the C-peptide segment of HPI, independently of the presence of ordered structure in the insulin moiety. A predicted beta-turn at position 47-50 may play an important role in bringing N- and C-terminal regions of the C-peptide segment into close proximity.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6207064     DOI: 10.2337/diab.33.10.1012

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  14 in total

1.  Expression of mutant Ins2C96Y results in enhanced tubule formation causing enlargement of pre-Golgi intermediates of CHO cells.

Authors:  Jing-Yu Fan; Jürgen Roth; Christian Zuber
Journal:  Histochem Cell Biol       Date:  2007-07-24       Impact factor: 4.304

Review 2.  Applications of immunogold and lectin-gold labeling in tumor research and diagnosis.

Authors:  J Roth; C Zuber; P Komminoth; T Sata; W P Li; P U Heitz
Journal:  Histochem Cell Biol       Date:  1996-07       Impact factor: 4.304

3.  The insulin factory: a tour of the plant surroundings and a visit to the assembly line. The Minkowski lecture 1973 revisited.

Authors:  L Orci
Journal:  Diabetologia       Date:  1985-08       Impact factor: 10.122

4.  Use of a synthetic peptide antigen to generate antisera reactive with a proteolytic processing site in native human proinsulin: demonstration of cleavage within clathrin-coated (pro)secretory vesicles.

Authors:  D F Steiner; J Michael; R Houghten; M Mathieu; P R Gardner; M Ravazzola; L Orci
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

5.  Sequence of a New World primate insulin having low biological potency and immunoreactivity.

Authors:  S Seino; D F Steiner; G I Bell
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

6.  Biosynthesis of betagranin in pancreatic beta-cells. Identification of a chromogranin A-like precursor and its parallel processing with proinsulin.

Authors:  J C Hutton; H W Davidson; K A Grimaldi; M Peshavaria
Journal:  Biochem J       Date:  1987-06-01       Impact factor: 3.857

7.  Endocrine pancreatic tumors in MSV-SV40 large T transgenic mice.

Authors:  W Götz; C Schucht; J Roth; F Theuring; R Herken
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

8.  Topographic abnormalities of proinsulin to insulin conversion in functioning human insulinomas. Comparison of immunoelectron microscopic and clinical data.

Authors:  J Roth; P Komminoth; P U Heitz
Journal:  Am J Pathol       Date:  1995-08       Impact factor: 4.307

9.  Human Islets Contain a Beta Cell Type That Expresses Proinsulin But Not the Enzyme That Converts the Precursor to Insulin.

Authors:  Gladys Teitelman
Journal:  J Histochem Cytochem       Date:  2020-10       Impact factor: 2.479

10.  Conversion of proinsulin to insulin occurs coordinately with acidification of maturing secretory vesicles.

Authors:  L Orci; M Ravazzola; M Amherdt; O Madsen; A Perrelet; J D Vassalli; R G Anderson
Journal:  J Cell Biol       Date:  1986-12       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.